FDA Inspection 1277270 - Surmasis Pharmaceutical, LLC - August 01, 2025

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Surmasis Pharmaceutical, LLC

Record Details

This FDA Inspection record concerns Surmasis Pharmaceutical, LLC, with an inspection on August 1, 2025, issued by the Kansas City District Office, covering human drugs.

Company: Surmasis Pharmaceutical, LLC
Inspection Date: August 1, 2025
Product Type: Human Drugs
Office: Kansas City District Office

Open in Dashboard

ID · 5fb29e39-e823-41b8-9d3c-db716adf874c

Violation Codes4

21 CFR 211.19221 CFR 211.22(d)21 CFR 820.20(c)21 CFR 820.20(d)

Full citation text and observation details available on the Dashboard.